Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00454415 · ClinicalTrials.gov registry record
Prospective Study of Dietary Factors, BMI, and Risk of Asthma in Children
A clinical trial of Asthma, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 16,000
- Enrollment target
- 1
- Study location
NCT00454415 is a study of Asthma that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 16,000 participants, above the 1,521-participant average among 374 other Asthma trials with a reported enrollment target (952% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00454415, a study of Asthma, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 16,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Asthma is a common illness among children in the United States. While there are many known causes of asthma, including tobacco smoke, pollen, dust, or other allergens, the exact cause of asthma in some individuals remains unknown. This study will examine the role that specific dietary factors and body mass index (BMI) play in the development of childhood asthma.
Conditions Studied
Study Locations (1)
Massachusetts
- Channing Laboratory, Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16,000 participants |
| Start Date | 2007-01 |
| Est. Completion | 2008-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00454415
The ClinicalTrials.gov registry entry for NCT00454415 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,521-participant average among 374 other Asthma trials with a reported enrollment target (952% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 0 interventions.
NCT00454415 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00454415 about?
NCT00454415 is a clinical study titled "Prospective Study of Dietary Factors, BMI, and Risk of Asthma in Children". Asthma is a common illness among children in the United States. While there are many known causes of asthma, including tobacco smoke, pollen, dust, or other allergens, the exact cause of asthma in some individuals remains unknown. This study will examine the role that specific dietary factors and bo...
What is the current status of trial NCT00454415?
This trial is currently completed. The enrollment target is 16,000 participants. The study started on 2007-01. Estimated completion is 2008-12.
What conditions does trial NCT00454415 study?
This clinical trial studies the following conditions: Asthma.
Who is sponsoring clinical trial NCT00454415?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00454415 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Innate Immunity in Allergic Asthma
RECRUITING
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Impact of Metabolic Dysfunction and Mucus Plugging on Asthma Physiology
RECRUITING
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.